Trial Profile
A Study About Pharmacokinetic and Pharmacodynamics of Ramosetron in Chemotherapy Induced Nausea and Vomiting
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Sep 2016
Price :
$35
*
At a glance
- Drugs Ramosetron (Primary)
- Indications Postoperative nausea and vomiting
- Focus Pharmacokinetics
- 13 Sep 2016 New trial record.